Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
5
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
5
×
texas blog main
5
×
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
cancer
cancer immunotherapy
deals
drug prices
eli lilly
abbvie
bristol-myers squibb
clinical trials
generic drugs
What
bio
roundup
drug
alzheimer’s
companies
pharmaceutical
price
prices
acquisitions
albert
annual
appetite
approval
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
black
bourla
bread
butter
buyout
cancer
cash
ceo
communities
company
conference
convo
crispr
diabetes
diamond’s
different
drugs
earlier
eli
esmo
europe
Language
unknown
Current search:
medicare
×
startups
×
" texas blog main "
×
" san diego top stories "
×
biotech
×
photo
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More